South Africa - 2019 - Health

Interim Clinical Guidance for the Implementation of Injectable-Free Regimens for Rifampicin-Resistant Tuberculosis in Adults, Adolescents and Children

Ministry of Health, South Africa

This guidance outlines the interim clinical guidelines on the implementation of the modified short and long treatment regimens for people with Rifampicin Resistant Tuberculosis (RR-TB) in South Africa.

Process Flow

Compare Versions Please select two versions

Interim Clinical Guidance for the Implementation of Injectable-Free Regimens for Rifampicin-Resistant Tuberculosis in Adults, Adolescents and Children Current Version

January 2022

This guidance outlines the interim clinical guidelines on the implementation of the modified short and long treatment regimens for people with Rifampicin Resistant Tuberculosis (RR-TB) in South Africa.

Request Expert Analysis

Ask one of our policy analysts to take an in-depth look at this policy and provide you with a written summary. An additional cost may apply. Please let us know what questions you are looking to answer.

Thank you for requesting an expert analysis

A member of our team will review your request and reply back to the email address on file.